Description

Book Synopsis
Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry, clinical applications and potential side effects of Ribavirin. Topics include optimising Ribavirin use for the treatment of Hepatitis C; Ribavirin and its great potential in infectious diseases; the antiviral actions of Ribavirin; a novel prediction method for the responsiveness of Hepatitis C patients to drug treatment; and Ribavirin''s intolerable cough during HCV combination therapy which can be overcome by replacement with Nitazoxanide.

Ribavirin: Biochemistry, Clinical Applications &

    Product form

    A Paperback / softback by Joris Buskirk

    £79.04

    Includes FREE delivery

    RRP £92.99 – you save £13.95 (15%)

    Order before 4pm today for delivery by Wed 9 Sep 2026.

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Ribavirin: Biochemistry, Clinical Applications & by Joris Buskirk

      Book details

      Publisher Nova Science Publishers Inc
      Published 1 December 2013
      ISBN-13 9781628088137
      978-1628088137
      ISBN-10 1628088133
      Also in:
      Pharmacology

      Description

      Book Synopsis
      Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry, clinical applications and potential side effects of Ribavirin. Topics include optimising Ribavirin use for the treatment of Hepatitis C; Ribavirin and its great potential in infectious diseases; the antiviral actions of Ribavirin; a novel prediction method for the responsiveness of Hepatitis C patients to drug treatment; and Ribavirin''s intolerable cough during HCV combination therapy which can be overcome by replacement with Nitazoxanide.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account